News

Monday February 25, 2019

25 Feb 2019 – Edison Investment Research publish Research Note on Destiny Pharma e...

Edison Investment Research Limited today published a Research Note on Destiny Pharma by Analyst Andy Smith entitled “Prevention is commercially cost effective”.  The research can be found here and the […]